The clinical management of patients with non-acute myocardial ischaemic syndrome (NAMIS) continues to evolve as increasingly effective treatment approaches become available. In this Review, Chiu et al. summarize the evidence from randomized trials on optimal medical therapy with or without percutaneous coronary intervention or coronary artery bypass graft surgery to guide shared decision making in patients with NAMIS.
- Nicholas Chiu
- Deepak L. Bhatt
- William E. Boden
